- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Laboratorios Farmaceuticos Rovi SA
+ Add to Watchlist41L:GR
6.807 EUR 0.098 1.42%As of 02:04:22 ET on 06/19/2013.
Snapshot for Laboratorios Farmaceuticos Rovi SA (41L)
| Open: | 6.804 | Day's Range: | 6.804 - 6.807 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 6.905 | 52wk Range: | 4.818 - 6.972 | 1-Yr Rtn: | +40.67% |
Key Statistics for 41L
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 14.4830 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (EUR) (ttm) | - |
| Est. EPS (EUR) (12/2013) | 0.4700 |
| Est. PEG Ratio | 0.5528 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 1.99% |
| Cash Dividend (EUR) | 0.1079 |
| Last Dividend | 07/03/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 41L
Company Profile & Key Executives for 41L
Laboratorios Farmaceuticos Rovi SA is a specialty pharmaceutical company. The Company researches, develops, manufactures, and markets small molecule and specialty biologic drugs. Rovi's services include contract manufacturing of aseptic filling and packaging of small-volume parenterals in prefilled syringes and vials and provides temperature-controlled storage facilities.
| Juan Lopez-Belmonte LopezChairman/Co-CEO | Juan Lopez-Belmonte EncinaCo-CEO/General Director |
| Javier Lopez-Belmonte EncinaChief Financial Officer | Francisco Javier Angulo GarciaDir:Human Resources |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
41L News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page